Melanie Morel-Ferris
2017
In 2017, Melanie Morel-Ferris earned a total compensation of $382.9K as Former Chief Financial Officer at InVivo Therapeutics Holdings.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $89,066 |
| Salary | $159,373 |
| Stock Awards | $75,000 |
| Other | $9,468 |
| Total | $382,907 |
Morel-Ferris received $159.4K in salary, accounting for 42% of the total pay in 2017.
Morel-Ferris also received $50K in bonus, $89.1K in option awards, $75K in stock awards and $9.5K in other compensation.
Rankings
In 2017, Melanie Morel-Ferris' compensation ranked 12,714th out of 14,666 executives tracked by ExecPay. In other words, Morel-Ferris earned more than 13.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,714 out of 14,666 | 13th |
Division Manufacturing | 5,001 out of 5,772 | 13th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 716 out of 859 | 17th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 435 out of 531 | 18th |
Industry Surgical and Medical Instruments and Apparatus | 282 out of 336 | 16th |
Source: SEC filing on April 27, 2018.
Morel-Ferris' colleagues
We found six more compensation records of executives who worked with Melanie Morel-Ferris at InVivo Therapeutics Holdings in 2017.
2017
Mark Perrin
InVivo Therapeutics Holdings
Chief Executive Officer
2017
Richard Toselli
InVivo Therapeutics Holdings
Chief Executive Officer
2017
Thomas Ulich
InVivo Therapeutics Holdings
Chief Scientific Officer
2017
Tamara Joseph
InVivo Therapeutics Holdings
General Counsel
2017
Christopher McNulty
InVivo Therapeutics Holdings
Chief Financial Officer
2017
Pamela Stahl
InVivo Therapeutics Holdings